Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis
Abstract
Introduction Individuals with chronic lung disease (eg, cystic fibrosis (CF)) often receive antimicrobial therapy including aminoglycosides resulting in ototoxicity. Extended high-frequency audiometry has increased sensitivity for ototoxicity detection, but diagnostic audiometry in a sound-booth is costly, time-consuming and requires a trained audiologist. This cross-sectional study analysed tablet-based audiometry (Shoebox MD) performed by non-audiologists in an outpatient setting, alongside home web-based audiometry (3D Tune-In) to screen for hearing loss in adults with CF. Methods Hearing was analysed in 126 CF adults using validated questionnaires, a web self-hearing test (0.5 to 4 kHz), tablet (0.25 to 12 kHz) and sound-booth audiometry (0.25 to 12 kHz). A threshold of ≥25 dB hearing loss at ≥1 audiometric frequency was considered abnormal. Demographics and mitochondrial DNA sequencing were used to analyse risk factors, and accuracy and usability of hearing tests determined. Results Prevalence of hearing loss within any frequency band tested was 48%. Multivariate analysis showed age (OR 1.127; (95% CI: 1.07 to 1.18; p value0.9) at all frequencies ≥4 kHz. Conclusions Adults with CF have a high prevalence of drug-related hearing loss and tablet-based audiometry can be a practical, accurate screening tool within integrated ototoxicity monitoring programmes for early detection.Keywords
Funding Information
- NHS Darzi Fellowship in Clinical Leadership
- Cystic Fibrosis Trust (Clinical Innovation and Excellence Award)
This publication has 38 references indexed in Scilit:
- The Net Promoter Score – an asset to patient experience surveys?Health Expectations, 2014
- Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?International Journal of Pediatric Otorhinolaryngology, 2014
- Assessing treatment outcomes using a single questionThe Bone & Joint Journal, 2014
- Extended high-frequency (9–20 kHz) audiometry reference thresholds in 645 healthy subjectsInternational Journal of Audiology, 2014
- Unipro UGENE: a unified bioinformatics toolkitBioinformatics, 2012
- Hearing in 44–45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort studyBMJ Open, 2012
- A mutation in mitochondrial 12S rRNA, A827G, in Argentinean family with hearing loss after aminoglycoside treatmentBiochemical and Biophysical Research Communications, 2008
- Retest Stability of the Tinnitus Handicap QuestionnaireAnnals of Otology, Rhinology & Laryngology, 1995
- Test-Retest Reliability of the Hearing Handicap Inventory for AdultsEar & Hearing, 1991
- Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacinAntimicrobial Agents and Chemotherapy, 1983